4.1 Article

High ratio of C-reactive protein/procalcitonin predicts Mycoplasma pneumoniae infection among adults hospitalized with community acquired pneumonia

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/00365513.2020.1858491

Keywords

Community acquired pneumonia; Mycoplasma pneumoniae; C-reactive protein; procalcitonin; C-reactive protein; procalcitonin ratio; respiratory infections

Funding

  1. National Science Foundation of China [81960363]
  2. Yunnan health training project of high level talents [H-2019045]
  3. Yunnan Fundamental Research Projects [202001BA070001-151, 202001BA070001-161]

Ask authors/readers for more resources

This retrospective study analyzed data from inpatients diagnosed with CAP at the First Affiliated Hospital of Dali University between January 2018 and June 2020. The findings suggest that CRP/PCT >350 μg/ng may serve as a potential index for distinguishing MP infections from other types of pneumonia.
There is limited data on serum biomarkers in distinguishing Mycoplasma pneumoniae (MP) from Streptococcus pneumoniae (SP) and viral pneumoniae (VP) etiologies of community-acquired pneumonia (CAP). A retrospective study of inpatients diagnosed with CAP at the First Affiliated Hospital of Dali University (Dali, Yunnan, China) between January 2018 and June 2020 was conducted. The demographic, clinical and laboratory data of the patients with CAP were analyzed. Univariate analyses identified predictors for MP infections. The discriminative power of C-reactive protein (CPR), procalcitonin (PCT), CRP/PCT and CPR/PCT >350 mu g/ng was assessed by area under the curve (AUC) of the receiver operating characteristic (ROC) curves. A total of 552 CAP patients, including 247 (44.7%) with MP, 152 (27.6%) with SP and 153 (27.7%) with influenza A and B viruses, were enrolled. When comparing MP with SP, cough and CRP/PCT >350 mu g/ng (odds ratio [OR]) 2.88, p < .001) were predictors for MP. CRP/PCT >350 mu g/ng had 76% sensitivity and 100% specificity (AUC = 0.89, p < .001, 95% confidence interval [CI]:0.81-0.94) to predict MP infections. Furthermore, similar results were again obtained when comparing MP with VP. CRP/PCT >350 mu g/ng present better information (OR: 4.70; AUC = 0.92, p < .001, 87% sensitivity and 100% specificity). In addition, comparing MP and non-MP (SP and VP combined), CRP/PCT >350 mu g/ng exhibited excellent performance (AUC = 0.90, 95%CI 0.83-0.95, p < .001, 76% sensitivity and 100% specificity). CRP/PCT ratio may be a potential index to distinguish MP-CAP from non-MP-CAP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available